EFTA01461556.pdf

From: Tazia Smith Sent: 4/16/2014 11:45:54 AM To: [email protected] CC: Nav Gupta . Paul Morris Vahe Stepanian ; Vinit Sahni Subject: Re: Biotech Update... note bounce in Foundation Medine on withdrawal of prior secondary offering (Cl Classification: Confidential Jeffrey - Uptick in Biotech today ahead of earnings for the big caps (biogen, gilead, celgene) next week. Your positions below with P/L. Please note that your Foundation Medicine has really bounced off it's recent lows of $—$24 (chart below); yesterday the company withdrew a prior filing for a $150mm secondary offering. We break out Ariad because it is more M&A driven at this point than sector beta. As ot 4/16/14 11.23 pm PS_LAST Description Trade Date Quantity Current Price Unit Cost Market Value Current Total Cost Unrealized G/L SANGAMO 0105CIENCES 5/25/201.3 50,000.00 0 14.12 6 8.44 1 706,000.00 422,214.00 6 283,786,00 'MOGEN 2/14/2012 2,095.00 $ 290.72 $ 119.55 $ 609,058.40 250,454.95 6 358,603.45 FOUNDATION MEDICINE 1/13/2014 25,000.00 0 27.27 A 27.51 $ 681,6:9.00 687,663.50 6 (60343.50) GILEAD SCIENCES INC Multiple/ 6,100.00 5 69.31 4 79.41 4 5,ACD90 643,204.00 $ (81,301,1.0) Total Illoidoth $ 2,558,086.30 0 2,003,536.45 $ 554,549.85 ARIAD PHARMACEUTICALS Multiple 16,535.00 6.63 17.60 S 112.934.05 290,997.40 (178,063.35) .2 b 25.5. • 26.30 aue Wk - i o - " Va.< Daily Track Annotate Ne Zoom ^- 4.1 D• Last Price 27.28 +40 T High on 03/13/14 43.62 -IP- Average 29.7273 35 I Low an 11/14/13 20.42 OEM +20 iy• Volume 0.2SSM SM,AV9 0 , Ribinolttialla/t .289M Arta% ;alum wartoralkitiliftraill Nov Dec Jan Feb Mar Apr 2013 2014 From: Tazia Smith/dbldbcom To: jeevacation©gmail corn. Cs. Paul Moms. Vaho StepantandLudbcortsgDBAmencas. Nay Guptaidbedbcom@DBEMEA. ViM Sahmdbdbcom@DBEMEA. nchardkahn12@gmancom Date 04'02/2014 03:42 PM Subject Biotech Update... IC) CONFIDENTIAL - PURSUANT TO FED. R. CRIM. P. 6(e) DB-SDNY-0 123682 CONFIDENTIAL SDNY_GM_00269866 EFTA01461556